Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C
The introduction of tirzepatide, the first dual agonist targeting both the GLP-1R and the glucose-dependent insulinotropic polypeptide (GIP) receptor, represents a new frontier in incretin-based therapy (Syed, 2022
Everyone who signs up for Sunnyside gets a free 15-day trial, then the subscription is $8.25/month
"So, you want to make sure that your doctor is on board and is aware of what youre doing." Consumers are also urged never to share personal health or insurance information without first confirming a company is legitimate
Navigating the GLP-1 Wave: A Strategic Guide for Plan Sponsors Pain Point : Theres a lack of clear guidance on how to best incorporate and manage coverage for new and expensive GLP-1 medications into existing health plans
Known for its psychology-based approach to weight loss, Noom now offers compounded semaglutide and brand-name Zepbound alongside structured coaching, nutrition guidance, and accountability tools